PharmAust Limited

ASX:PAA.AX

0.23 (AUD) • At close October 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Revenue 02.8243.3812.143.1964.3473.2593.3082.7182.3711.9391.711.6181.5521.6411.7562.7957.1316.1063.2110.3060.0680.6780
Cost of Revenue 0.0023.7533.6052.9123.620.3340.2890.3410.2340.2080.2230.2210.1770.1420.2090.1940.7113.0181.8411.3180.1390.0350.1480
Gross Profit -0.002-0.93-0.224-0.772-0.4244.0132.972.9672.4842.1641.7171.491.4411.411.4311.5622.0834.1134.2651.8930.1670.0330.530
Gross Profit Ratio 0-0.329-0.066-0.36-0.1330.9230.9110.8970.9140.9120.8850.8710.8910.9080.8720.890.7460.5770.6980.590.5470.4820.7810
Reseach & Development Expenses 3.8471.0320.7590.5540.6051.0390.4640.3290.7020.6290.2120000000000.053000
General & Administrative Expenses 01.6611.7671.4641.1421.4091.3551.3021.7471.2471.1092.0532.2372.182.0031.9142.084.9034.5473.6341.0591.4261.630
Selling & Marketing Expenses 000002.9143.5622.5231.7772.181.725000000000000.7830
SG&A 2.811.6611.7671.4641.1424.3234.9173.8253.5253.4272.8332.0532.2372.182.0031.9142.084.9034.5473.6341.0591.4262.4130
Other Expenses 00.9951.1291.5170.9240.6760.3880.4530.70.5020.0590.0533.4320.010.1221.816-0.8030.0030.7430.0220.0440.089-3.723-2.382
Operating Expenses 6.6572.6932.5262.0181.7475.5345.54.2776.4084.1343.12.1065.6692.2492.0652.1844.64910.477.583.8611.3372.0960.5780.251
Operating Income -6.659-3.623-2.749-2.79-2.171-1.521-2.53-1.31-1.853-1.97-1.383-0.616-4.228-5.837-0.634-0.622-2.565-6.302-3.315-1.817-0.993-1.974-3.725-0.251
Operating Income Ratio 0-1.283-0.813-1.303-0.679-0.35-0.776-0.396-0.682-0.831-0.713-0.36-2.613-3.76-0.386-0.354-0.918-0.884-0.543-0.566-3.24-29.044-5.4930
Total Other Income Expenses Net -2.795-2.5891.0411.4520.809-0.030.009-0.033-2.0750.0450.065-0.023-0.033-4.9890.1220.426-3.1380.0030.593-1.289-1.2660.089-3.723-2.382
Income Before Tax -9.453-6.212-1.708-1.337-1.362-1.551-2.522-1.344-3.927-1.925-1.318-0.639-4.26-5.798-0.439-0.18-5.768-6.575-2.752-3.364-2.585-2.073-3.705-2.094
Income Before Tax Ratio 0-2.2-0.505-0.625-0.426-0.357-0.774-0.406-1.445-0.812-0.68-0.374-2.633-3.735-0.267-0.102-2.064-0.922-0.451-1.048-8.434-30.5-5.4650
Income Tax Expense -0.55300-000.00100000-0.1140.0080.0140.2280.57-2.2320.2830.82-3.364-2.585-2.073-3.705-2.094
Net Income -9.032-6.212-1.708-1.337-1.362-1.551-2.522-1.344-3.927-1.925-1.318-0.515-4.26-5.798-0.439-0.18-5.768-6.575-2.752-3.3640.037-2.073-3.705-2.094
Net Income Ratio 0-2.2-0.505-0.625-0.426-0.357-0.774-0.406-1.445-0.812-0.68-0.301-2.633-3.735-0.267-0.102-2.064-0.922-0.451-1.0480.12-30.5-5.4650
EPS -0.024-0.019-0.005-0.004-0.005-0.007-0.017-0.011-0.043-0.025-0.02-0.017-0.16-0.36-0.03-0.013-0.48-1.05-0.61-1-1.35-1.58-3.44-2.58
EPS Diluted -0.024-0.019-0.005-0.004-0.005-0.007-0.017-0.011-0.043-0.025-0.02-0.017-0.16-0.36-0.03-0.013-0.48-1.05-0.61-1-1.35-1.58-3.44-2.58
EBITDA -6.657-3.296-2.434-2.491-1.896-1.349-2.412-1.187-1.743-1.893-1.33-0.557-4.162-0.73-0.2710.022-4.566-5.485-2.106-1.924-1.02-1.283-3.045-1.844
EBITDA Ratio 0-1.167-0.72-1.164-0.593-0.31-0.74-0.359-0.641-0.798-0.686-0.326-2.573-0.47-0.1650.013-1.634-0.769-0.345-0.599-3.33-18.874-4.4910